Images:Getty,UnsplashContentsForeword3Executive summary41 Introduction51.1 The case for gene therapies in LMICs51.2 Using this report52 Landscape72.1 The rise of gene therapies72.2 Expectations for innovation and the eoonomy82.3 A widening global gap93 Capacity pillars103.1 Research and development103.2 Health facilities123.3 Manufacturing143.4 Workforce153.5 Community engagement173.6 Policy and regulation183.7 Finance204 Case studies2222Case study 2:Tanzania23Case study 3:South Africa24Case study 4:Thailand25Case study 5:India265 Questions27Conclusion28ContributorsEndnotes30DisclaimerWorld Economic Forum as a contributionto a project,insight area or interaction.The findings,interpretations andForum,nor the entirety of its Members,Accelerating Global Access to Gene Therapies:Case Studies from Low-and Middle-Income Countries2